Latest from Oxehealth
Oxehealth has announced another world first after the US Food and Drug Administration granted a De Novo clearance for its Oxehealth Vital Signs product.
Oxehealth's Oxevision named one of 12 high impact innovations to join the NHS Innovation Accelerator in 2021.
Oxehealth is proud to have been included in the Department for International Trade's Digital Health Campaign - 'The First 100 Playbook'.
Starting off 2021 strong by scooping up HTN's "Excellence in remote monitoring" Award!
Oxehealth is delighted to announce that, with our partners; South London and Maudsley FT, Oxford Health, Coventry and Warwickshire Partnership Trust, we have been shortlisted for FOUR separate HSJ Partnership Awards!
Innovative technology is being installed on mental health wards at Midlands Partnership NHS Foundation Trust (MPFT) as part of a programme to continuously improve patient safety